Biotechnology

Techseriesinsight > Blog > News > Biotechnology

Orchestra Life Sciences Named No. 203 on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies

August 13, 2026
Business Wire
Biotechnology, News

Jupiter Endovascular Appoints Catalin Toma, MD, as Chief Medical Officer

Jupiter Endovascular Inc., a medical technology company developing a new class of endovascular interventions based on its proprietary Transforming Fixation (TFX) technology, today announced the appointment of renowned interventional...

August 11, 2026
PRNewswire
Biotechnology, News

Orchestra Life Sciences Named No. 203 on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies

Orchestra Life Sciences, a technical consultancy specializing in advanced therapy manufacturing solutions, today announced that it has been ranked No. 203 on the 2026 Inc. 5000 list, the annual ranking...

SonicWall Earns Clean Sweep of 2026 CRN Annual Report Card

August 10, 2026
PRNewswire
Biotechnology, News

Acarix Receives Regulatory Approval for the CADScor® System in the UAE

Acarix AB (publ) today announced that the CADScor® System has received regulatory approval from the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP), clearing the way...

August 7, 2026
PRNewswire
Biotechnology, News

Caris Precision Oncology Alliance Welcomes the University of New Mexico Comprehensive Cancer Center

Caris Life Sciences® (Caris), a leading TechBio company, today announced that the University of New Mexico Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance® (Caris POA), a global...

August 5, 2026
Business Wire
Biotechnology, News

Clinilabs Announces Medical Leadership Appointments

Clinilabs, a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar...

August 4, 2026
PRNewswire
Biotechnology, News

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group, today announced a total capital injection of RMB 1.2397 billion (approximately US$184 million) into AsymBio...

August 4, 2026
Business Wire
Biotechnology, News

QuantHealth Raises $45 Million Series B, led by Qumra Capital, to Accelerate Simulation-First Clinical Trial Development

QuantHealth, a global leader in AI-driven clinical trial simulation, today announced a $45 million Series B. The round was led by Qumra Capital, with support from additional investors, including Pitango...

August 3, 2026
PRNewswire
Biotechnology, News

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company developing Designable Multi-Antivirals (D-MAVs™), today announced continued expansion of its intellectual property portfolio, which now comprises seven patent families covering compositions of...

July 30, 2026
PRNewswire
Biotechnology, News

Seoul National University of Science and Technology Researchers Show Perilla Oil Improves Blood Circulation and Coagulation in Healthy Smokers

Cardiovascular disease (CVD) is a leading cause of death worldwide and the second leading cause in South Korea, with incidence continuing to rise. This growing burden affects public health...

July 29, 2026
PRNewswire
Biotechnology, News

10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care

The life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Lausanne University Hospital (CHUV), one of Switzerland’s leading academic medical...